Interpretation
musculoskeletal PASC LE symptoms
Our study investigated the safety and potential benefits of a 4 week self‐administered E‐Stim therapy program in individuals with musculoskeletal PASC LE symptoms who were previously hospitalized. We found that a daily 1 h session of E‐Stim was both safe and well‐tolerated and may lead to improved muscle perfusion and endurance. Furthermore, we observed a potential benefit for GNM vascular improvement leading to a healthier HR2S. These findings suggest that E‐Stim therapy is a practical and promising intervention for individuals with musculoskeletal PASC LE symptoms seeking to improve their functional recovery.